We found that BC patients with TTN-AS1 gene high expression had worse DFS (cutoff high expression: 60% of all patients; cutoff low expression: 40% of all patients) (Figure 1A), and its expression has no prediction of OS (Figure 1B). Here, TTN is linked to breast cancer.